A Prospective Observational Study of Safety and Occurrence of Influenza-like Illness Following Administration of Adjuvanted Swine Origin A(H1N1) Pandemic Subunit Vaccine Focetria.
Phase of Trial: Phase I
Latest Information Update: 04 Oct 2011
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions; Therapeutic Use
- Sponsors Novartis; Novartis Vaccines
- 04 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Oct 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
- 07 Dec 2010 Actual patient number is 7284 as reported by ClinicalTrials.gov.